1. Canada Stocks

  2. •

    Healthcare

  3. •

    Drug Manufacturers - Specialty & Generic
CannTrust Holdings Inc.

CannTrust Holdings Inc.

CNTTQ
CannTrust Holdings Inc.US flagOther OTC
0.00
USD
- -
- -
1,412.00Market Cap
CannTrust Holdings Inc.
CNTTQ
(Other OTC)

Recent

price

0.00

P/E

ratio

- -

div

yld

- -

ROIC.AI

2014
2015
2016
2017
2018
TTM
FRC
- -
0.01
0.05
0.27
0.46
0.54
Revenue per Share
-0.15
-0.07
-0.15
0.09
-0.14
-0.12
Basic EPS, GAAP
-0.1
-0.06
-0.04
-0.4
-0.54
-0.73
Free Cash Flow per Basic Share
- -
- -
- -
- -
- -
- -
Dividend per Share
-0.08
-0.13
0.09
0.85
1.55
1.64
Book Value per Share
-0.08
-0.11
0.12
0.92
1.75
1.87
Tangible Book Value per Share
87
87
87
77
99
102
Basic Weighted Avg Shares
- -
1
4
21
46
55
Sales/Revenue/Turnover
- -
-751.54
-31.42
44.51
-19.32
-5.31
Operating Margin (%)
- -
1
1
2
4
4
Depreciation Expense
-13
-6
-13
7
-14
-12
Net Income, GAAP
- -
- -
- -
- -
- -
182.36
Effective Tax Rate (%)
- -
-1,053.67
-292.44
33.27
-29.69
-22.31
Profit Margin (%)
3
3
8
37
112
115
Working Capital
- -
1
1
1
10
2
LT Debt
-7
-10
10
71
174
190
Total Equity
- -
- -
- -
21.73
- -
30.88
Return on Invested Capital (%)
- -
- -
- -
18.77
- -
25.55
Return on Capital (%)
- -
- -
- -
18.95
-12.37
-9.86
Return on Common Equity (%)

Capital Structure

FRC

•

in mil. unless spec.
Sep'18
Dec'18
Mar'19
ST Debt
- -
4
13
LT Borrowings
10
10
- -
LT Finance Leases
- -
- -
2
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
104
106
106
Market Capitalization
1,236
640
1,054

Working Capital

FRC

•

in mil. unless spec.
Sep'18
Dec'18
Mar'19
Total Current Assets
154
128
140
Cash, Cash Equivalents & STI
86
72
43
Accounts Receivable, Net
2
6
3
Inventories
42
35
56
Total Current Liabilities
9
17
25
Payables & Accruals
8
13
11
ST Debt
- -
4
13
Deferred Revenue
- -
- -
- -

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
- -
- -
145.56%
Free Cash Flow
- -
- -
72.5%
Net Income, GAAP
- -
- -
-296.84%
Sales/Revenue/Turnover
- -
- -
120.53%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2017
3
5
6
7
21
2018
8
9
13
16
46
2019
17
- -
- -
- -
- -

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2017
-0.01
0.01
0.01
- -
0.09
2018
0.12
- -
- -
- -
-0.14
2019
0.12
- -
- -
- -
- -

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2017
- -
- -
- -
- -
- -
2018
- -
- -
- -
- -
- -
2019
- -
- -
- -
- -
- -
Similar Companies
Voyageur Pharmaceuticals Ltd. (VYYRF)
Mochida Pharmaceutical Co., Ltd. (4534.T)
Cann Group Limited (CNGGF)
Fagron N.V. (ARSUF)
Societal CDMO, Inc. (SCTL)
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd. (1349.HK)
Business
CannTrust Holdings Inc. produces and distributes medical and recreational cannabis products in Canada. The company offers dried cannabis flower, cannabis extracts and oils, and branded recreational products including Liiv and Synr.g; it previously developed nanotechnology-based offerings for medical, recreational, beauty, wellness, and pet markets. CannTrust operates primarily in the Canadian healthcare and consumer cannabis sectors, targeting medical patients and recreational consumers through licensed producers and provincial distributors. Founded in 2015 and headquartered in Vaughan, Ontario, the company maintains production facilities in Canada and focuses on standardized, pesticide-free cannabis for chronic healthcare applications. In recent years, CannTrust underwent significant restructuring, including court-approved CCAA proceedings commencing around 2020, implementation of a reorganization plan in early 2022 with new investment partners led by Marshall Fields International, and securing C$22.5 million in debtor-in-possession financing in 2021; it faced regulatory challenges such as license suspensions and compliance remediation at its Vaughan facility, workforce reductions of 20%, and strategic reviews, while returning to the Canadian recreational market in late 2020 with Liiv and Synr.g brands and planning medical portfolio relaunch.

Company News

APIChat

  • globenewswire.com

    Cannabis Cultivation Market Report 2025, with Profiles of Key Players Pacific Cannabis Growers, Atlas Growers, Canntrust, The Hydropothecary Corporation and Better Holdings

  • benzinga.com

    Cannabis Firm CannTrust Announce Settlement of Class Action Lawsuits and Board Changes

  • marketwatch.com

    Canadian cannabis company CannTrust developing 'orderly wind-down plan' after debt default

  • prnewswire.com

    CannTrust Announces Court Approval of Plan of Compromise, Arrangement and Reorganization

  • prnewswire.com

    CannTrust Announces Court Approval for C$22.5 Million Debtor-in-Possession and CCAA Exit Credit Facility Financing

  • prnewswire.com

    CannTrust Announces Change in Auditor

  • prnewswire.com

    CannTrust Announces the Issuance of CCAA Representation Order - Appointment of Representative Counsel for the Securities Claimants

  • thefly.com

    Rising High: CannTrust obtains order under CCAA as firms report earnings CTST;CRON;GNLN;HEXO;MEDIF;APHA;OGI;MJARF;ACB;CVSI;CGC;CANN;IGC;TLRY;TCNNF;ZYNE

  • zacks.com

    CannTrust (CTST) to Report Q4 Earnings: What's in Store?